REFERENCES
- Anand R, Boehm CD, Kazazian HH Jr, Vanin EF. Molecular charecterization of a β0-thalassemia resulting from a 1.4 kilobase deletion. Blood. 1988;72 (2):636–641.
- Thein SL, Hesketh C, Brown JM, Anstey AV, Weatherall DJ. Molecular charecterization of a high A2 β thalassemia by direct sequencing of single strand enriched amplified genomic DNA. Blood. 1989;73(4):924–930.
- Faustino P, Reis AB, Feliciano H, Asymptomatic homozygous deletional β0-thalassemia in an African individual. Am J Hematol. 2002;70(3):232–236.
- Padanilam BJ, Felice AE, Huisman THJ. Partial deletion of the 5′ β-globin gene region causes β0-thalassemia of an American Black family. Blood. 1984;64(4):941–944.
- Waye JS, Chui DHK, Eng B, Hb S/β0-thalassemia due to the ∼1.4kb deletion is associated with a relatively mild phenotype. Am J Hematol. 1991;38(2):108–112.
- Thein SL, Menzel S, Lathrop M, Garner C. Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum Molec Genet. 2009;18(R2):R216–R223.
- Mai M, Hoyer JD, McClure RF. Use of multiple displacement amplification to amplify genomic DNA before sequencing of the α and β haemoglobin genes. J Clin Pathol. 2004;57(6):637–640.
- Sutton M, Bouhassira E, Nagel R. Polymerase chain reaction amplification applied to the determination of β-like globin gene cluster haplotypes. Am J Hematol. 1989;32(1):66–69.